Compare TKNO & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TKNO | ALTI |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | 490 |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.1M | 407.2M |
| IPO Year | 2021 | 2021 |
| Metric | TKNO | ALTI |
|---|---|---|
| Price | $3.58 | $3.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 78.5K | ★ 157.0K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.86 | 41.11 |
| EPS | ★ N/A | N/A |
| Revenue | $40,520,000.00 | ★ $254,956,000.00 |
| Revenue This Year | $8.27 | $18.06 |
| Revenue Next Year | $13.13 | $10.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 7.35 | ★ 23.21 |
| 52 Week Low | $1.91 | $2.96 |
| 52 Week High | $6.86 | $5.45 |
| Indicator | TKNO | ALTI |
|---|---|---|
| Relative Strength Index (RSI) | 52.74 | 44.87 |
| Support Level | $2.55 | $3.28 |
| Resistance Level | $4.37 | $3.96 |
| Average True Range (ATR) | 0.32 | 0.24 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 32.62 | 38.05 |
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.